Subscribe To

Price Alert Latest News Economic Calendar News

MIRO / Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa

EDEN PRAIRIE, Minn., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that CEO Jeff Ross will present at the 2023 Cell & Gene Meeting on the Mesa in Carlsbad, CA. The three-day event, held this year on October 10-12, will feature presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas of cell therapy, gene therapy, gene editing, tissue engineering, and broader regenerative medicine technologies. Read More

Demo Live Account See Partner Details

Content Topics

Miromatrix

Jeff

Ross

Present

2023

Cell

Gene

Meeting

Mesa

Stock

MIRO

Posted: Oct 5 2023, 16:30

Author Name: GlobeNewsWire

MIRO News

By Proactive Investors
October 30, 2023

Miromatrix Medical climbs 225% following $140m United Therapeutics bid

Shares in the artificial human organs specialist Miromatrix Medical Inc. jumped 25% in premarket trading following the announcement of its acquisition

By InvestorPlace
October 30, 2023

Why Is Miromatrix Medical (MIRO) Stock Up 235% Today?

Miromatrix Medical (NASDAQ: MIRO ) stock is rocketing higher on Monday after announcing an acquisition deal with United Therapeutics (NASDAQ: UTHR )

By Market Watch
October 30, 2023

Miromatrix Medical stock soars after it agrees to be bought by United Therapeutics

Miromatrix Medical Inc.'s stock MIRO, -2.80% jumped 230% in premarket trades on Monday after the company agreed to be acquired by United Therapeutics

By GlobeNewsWire
October 5, 2023

Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa

EDEN PRAIRIE, Minn., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology f

By Seeking Alpha
August 19, 2023

Miromatrix Medical Inc. (MIRO) Q2 2023 Earnings Call Transcript

Miromatrix Medical Inc. (NASDAQ:MIRO ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Max Forgan - Gilmartin Investo

By Seeking Alpha
May 14, 2023

Miromatrix Medical Inc. (MIRO) Q1 2023 Earnings Call Transcript

Miromatrix Medical Inc. (NASDAQ:MIRO ) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Hannah Jeffrey - Gilmartin, Inves

By GlobeNewsWire
April 10, 2023

Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med

EDEN PRAIRIE, Minn., April 10, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology

By Seeking Alpha
March 31, 2023

Miromatrix Medical Inc. (MIRO) Q4 2022 Earnings Call Transcript

Miromatrix Medical Inc. (NASDAQ:MIRO ) Q4 2022 Earnings Conference Call March 31, 2023 4:30 PM ET Company Participants Hannah Jeffrey - Investor Relat

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.